Caroline joined Oxford Science Enterprises as Entrepreneur in Residence in February 2022.

As an Entrepreneur in Residence (EIR), Caroline will lead the creation and development of a new Health Tech enterprise. She has more than 25 years’ experience working in commercial, government and charitable organisations and before taking up the role, she was CEO of Health Data Research UK (HDR UK).

Under Caroline’s leadership HDR UK became established as the national institute for health data science and played a pivotal role in the UK’s pandemic response. She led the creation of the Health Data Research Hubs, which supported the RECOVERY Trial in identifying Dexamethasone as the first drug to be effective against COVID-19, the PRINCIPLE Trial in identifying Budesonide as the first treatment to shorten recovery time in patients not admitted to hospital, and the vaccine rollout by providing access to real-world evidence of vaccine effectiveness.

She also led the development of the Health Data Research Innovation Gateway, which is already transforming the scale and impact of UK health data research. Caroline also worked for The PSC where she was a founding director and prior to that she worked as an Engagement Manager at McKinsey & Company. She holds an MBA from Harvard Business School and MEng from the University of Cambridge.